Latest filing published 17 Sept 2007 for Vericel Corp, €8,070.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -80.4%Entry US$179.20 · Close at T+365 US$35.20
- +9.3%Entry US$206.40 · Close at T+365 US$225.60
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Stephen Sudovar: trading record in brief
Stephen Sudovar discloses dealings in 2 companies, chiefly Vericel Corp and Vaxart, Inc. Over a trading history stretching from 12 May 2006 to 14 September 2007, the count stands at 3 filings.
On the market, this insider has only ever bought: 2 purchases, €19k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 1 share grant. Since January 2007: 1 purchase and no sales on the market.
The record was last updated on 17 September 2007 with an open-market purchase (€8,070) in Vericel Corp. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Stephen Sudovar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$1.12Common StockSEC:0001209191-07-053651:0Canonical exit: 13 Dec 2007 (T+90)
- 10,000 shares@ US$1.37Common StockSEC:0001334692-06-000006:0Canonical exit: 16 Aug 2006 (T+90)
- 4,365 shares@ US$6.30Common StockSEC:0001278819-06-000024:0
3 of 3 declarations
